Literature DB >> 23420100

Predominant role of the dopamine D3 receptor subtype for mediating the quinpirole-induced inhibition of the vasopressor sympathetic outflow in pithed rats.

Inna Ruiz-Salinas1, Abimael González-Hernández, Guadalupe Manrique-Maldonado, Bruno A Marichal-Cancino, Alain H Altamirano-Espinoza, Carlos M Villalón.   

Abstract

We have recently reported that quinpirole (a D2-like receptor agonist) inhibits the vasopressor sympathetic outflow in pithed rats via sympatho-inhibitory D2-like receptors. Since D2-like receptors consist of D2, D3 and D4 receptor subtypes, this study investigated whether these subtypes are involved in the above quinpirole-induced sympatho-inhibition by using antagonists of these receptor subtypes. One hundred fifty-six male Wistar rats were pithed and prepared for preganglionic spinal (T7-T9) stimulation of the vasopressor sympathetic outflow. This approach resulted in frequency-dependent vasopressor responses which were analysed before and during i.v. continuous infusions of either saline (0.02 ml/min) or quinpirole (1 μg/kg.min) in animals receiving i.v. bolus injections of vehicle [saline or dimethyl sulfoxide (DMSO)] or the antagonists L-741,626 (D2), nafadotride or SB-277011-A (both D3) as well as L-745,870 (D4). Quinpirole inhibited the sympathetically-induced vasopressor responses. This sympatho-inhibition was (a) unaltered after 1 ml/kg saline, DMSO or 100 and 300 μg/kg L-741,626; (b) markedly blocked and abolished by, respectively, 30 and 100 μg/kg nafadotride or 100 and 300 μg/kg SB-277011-A and (c) slightly blocked after 30 and 100 μg/kg L-745,870, but 300 μg/kg L-745,870 produced no blockade whatsoever. Except for 300 μg/kg L-741,626 or 300 μg/kg L-745,870, the doses of the above compounds failed to modify per se the sympathetic vasopressor responses. The inhibition of the vasopressor sympathetic outflow induced by 1 μg/kg.min quinpirole in pithed rats is predominantly mediated by dopamine D3 and, to a lesser extent, by D4 receptor subtypes, with no evidence for the involvement of the D2 subtype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23420100     DOI: 10.1007/s00210-013-0841-8

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

Review 1.  Presynaptic signal transduction pathways that modulate synaptic transmission.

Authors:  Arthur P H de Jong; Matthijs Verhage
Journal:  Curr Opin Neurobiol       Date:  2009-06-24       Impact factor: 6.627

2.  Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.

Authors:  Y Satoh; J D Kohli; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

3.  The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D(2) -like type.

Authors:  Guadalupe Manrique-Maldonado; Abimael González-Hernández; Bruno A Marichal-Cancino; Ma Trinidad Villamil-Hernández; Oscar Alcántara-Vázquez del Mercado; David Centurión; Carlos M Villalón
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-08-08       Impact factor: 4.080

Review 4.  Dopamine receptor pharmacology.

Authors:  P Seeman; H H Van Tol
Journal:  Trends Pharmacol Sci       Date:  1994-07       Impact factor: 14.819

5.  Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.

Authors:  C M Villalón; J Contreras; E Ramírez-San Juan; C Castillo; M Perusquía; J A Terrón
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

6.  Vasopressor nerve responses in the pithed rat, previously identified as α2-adrenoceptor mediated, may be α1D-adrenoceptor mediated.

Authors:  James R Docherty
Journal:  Eur J Pharmacol       Date:  2011-03-02       Impact factor: 4.432

7.  Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.

Authors:  C Reavill; S G Taylor; M D Wood; T Ashmeade; N E Austin; K Y Avenell; I Boyfield; C L Branch; J Cilia; M C Coldwell; M S Hadley; A J Hunter; P Jeffrey; F Jewitt; C N Johnson; D N Jones; A D Medhurst; D N Middlemiss; D J Nash; G J Riley; C Routledge; G Stemp; K M Thewlis; B Trail; A K Vong; J J Hagan
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

8.  S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

Authors:  M J Millan; A Gobert; A Newman-Tancredi; F Lejeune; D Cussac; J M Rivet; V Audinot; T Dubuffet; G Lavielle
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

9.  The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.

Authors:  A H Altamirano-Espinoza; A González-Hernández; G Manrique-Maldonado; B A Marichal-Cancino; I Ruiz-Salinas; C M Villalón
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

10.  Inhibitory effects of catecholamines in the paravertebral sympathetic ganglia of the anesthetized dog.

Authors:  G Mercuro; P T Horn; E R Orelind; J D Kohli
Journal:  Eur J Pharmacol       Date:  1990-08-21       Impact factor: 4.432

View more
  3 in total

1.  Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge.

Authors:  José Ángel García-Pedraza; Asunción Morán; María Luisa Martín; Claudia Ollauri-Ibáñez; Alicia Rodríguez-Barbero; Carlos M Villalón; Mónica García-Domingo
Journal:  Pflugers Arch       Date:  2020-08-21       Impact factor: 3.657

2.  The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.

Authors:  A H Altamirano-Espinoza; A González-Hernández; G Manrique-Maldonado; B A Marichal-Cancino; I Ruiz-Salinas; C M Villalón
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 3.  Monoaminergic Receptors as Modulators of the Perivascular Sympathetic and Sensory CGRPergic Outflows.

Authors:  Bruno A Marichal-Cancino; Abimael González-Hernández; Enriqueta Muñoz-Islas; Carlos M Villalón
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.